Saudi Arabia stands as one of the leading countries for COVID-19 containment by Fadilah Sfouq Aleanizy, Fulwah Yahya Alqahtani, Jouri Alanazi, Hajar AlQahtani, Marzouqah Alanazi

Connect to this object online.

Evaluation of the Clinical Outcome and Cost Analysis of Antibiotics in the Treatment of Acute Respiratory Tract Infections in the Emergency Department in Saudi Arabia by Menyfah Q. Alanazi, Hajar AlQahtani, Thamer A. Almangour, Fadilah Sfouq Aleanizy, Fulwah Yahya Alqahtani

Connect to this object online.

Infections and patterns of antibiotic utilization in support and comfort care patients: A tertiary care center experience by Ebrahim Mahmoud, Reem Abanamy, Eman Binawad, Hind Alhatmi, Ali Alzammam, Abdulrahman Habib, Dana Alturaifi, Ahmed Alharbi, Hajar Alqahtani, Mohammed Aldohayan

Connect to this object online.

Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia by Hajar AlQahtani, Sara AlBilal, Ebrahim Mahmoud, Omar Aldibasi, Ahmad Alharbi, Nour Shamas, Abdulrahman Alsaedy, Kenana Owaidah, Fulwah Yahya Alqahtani, Fadilah Sfouq Aleanizy, Hatim Arishi, Saleem Baharoon, Mohammad Bosaeed

Connect to this object online.

Clinical characteristics and risk factors of patients with severe COVID-19 in Riyadh, Saudi Arabia: A retrospective study by Fadilah S. Aleanizy, Fulwah Y. Alqahtani, Marzouqah S. Alanazi, Rania A.E.H. Mohamed, Bahauddeen M. Alrfaei, Mana M. Alshehri, Hajar AlQahtani, Ghalia Shamlan, Nassr Al-Maflehi, Maha M. Alrasheed, Ahmed Alrashed

Connect to this object online.